Natriuretic Peptides and Normal Body Fluid Regulation

Abstract

Natriuretic peptides are structurally related, functionally diverse hormones. Circulating atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are delivered predominantly by the heart. Two C-type natriuretic peptides (CNPs) are paracrine messengers, notably in bone, brain, and vessels. Natriuretic peptides act by binding to the extracellular domains of three receptors, NPR-A, NPR-B, and NPR-C of which the first two are guanylate cyclases. NPR-C is coupled to inhibitory proteins. Atrial wall stress is the major regulator of ANP secretion; however, atrial pressure changes plasma ANP only modestly and transiently, and the relation between plasma ANP and atrial wall tension (or extracellular volume or sodium intake) is weak. Absence and overexpression of ANP-related genes are associated with modest blood pressure changes. ANP augments vascular permeability and reduces vascular contractility, renin and aldosterone secretion, sympathetic nerve activity, and renal tubular sodium transport. Within the physiological range of plasma ANP, the responses to step-up changes are unimpressive; in man, the systemic physiological effects include diminution of renin secretion, aldosterone secretion, and cardiac preload. For BNP, the available evidence does not show that cardiac release to the blood is related to sodium homeostasis or body fluid control. CNPs are not circulating hormones, but primarily paracrine messengers important to ossification, nervous system development, and endothelial function. Normally, natriuretic peptides are not powerful natriuretic/diuretic hormones; common conclusions are not consistently supported by hard data. ANP may provide fine-tuning of reno-cardiovascular relationships, but seems, together with BNP, primarily involved in the regulation of cardiac performance and remodeling. © 2017 American Physiological Society. Compr Physiol 8:1211-1249, 2018.

Natriuretic peptides relax human intrarenal arteries through natriuretic peptide receptor type‐A recapitulated by soluble guanylyl cyclase agonists

“…In healthy humans, plasma concentration of natriuretic peptides 23 is lower than the effective in vitro concentrations in the present study and previous studies 23,24 . This difference could be due to the reduced ex vivo preparation and it could also relate to the size of the vascular segment.…”

Cardiovascular biomarkers predict fragility fractures in older adults

“…MR-proANP is a precursor fragment of vasodilating and diuretic hormone that controls vascular permeability and contractility, renin and aldosterone secretion, sympathetic nerve activity and renal tubular sodium transport 24. Elevated levels of MR-proANP have been linked to delayed OH 9.…”

Vasoactive Biomarkers Associated With Long-Term Incidence of Symptomatic Peripheral Arterial Disease and Mortality

“…18 Atrial natriuretic peptide has been associated with lower blood pressure due to decreased activity of the renin angiotensin aldosterone system, and has been shown to inhibit endothelial hyperpermeability secondary to different inflammatory stimuli, suggesting a vasoprotective ability. 19 The increased levels of MR-proANP shown in patients with reduced long-term survival may reflect a physiological response to the inflammatory, and hemodynamic changes typically associated with CVD.…”